Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04800822
Title PF-07284892 in Participants With Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Pfizer

lung non-small cell carcinoma

colorectal cancer

Advanced Solid Tumor



Cetuximab + Encorafenib + PF-07284892

Lorlatinib + PF-07284892

Binimetinib + PF-07284892

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
UC Irvine Health Recruiting Orange California 92868 United States Details
START Midwest Recruiting Grand Rapids Michigan 49546 United States Details
Memorial Sloan Kettering Cancer Center David H Koch Center for Cancer Care Recruiting New York New York 10021 United States Details
Memorial Sloan Kettering Cancer Center Rockefeller Outpatient Pavilion Recruiting New York New York 10022 United States Details
Tennessee Oncology, PLLC Recruiting Franklin Tennessee 37067 United States Details
Tennessee Oncology PLLC Recruiting Nashville Tennessee 37203 United States Details
The University of Texas MD Anderson Cancer Center Recruiting Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from for the field